Northwestern Mutual Wealth Management’s Armata Pharmaceuticals ARMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.7K | Hold |
571
| – | – | ﹤0.01% | 3491 |
|
|
2026
Q1 | $5.85K | Hold |
571
| – | – | ﹤0.01% | 3255 |
|
|
2025
Q4 | $3.59K | Hold |
571
| – | – | ﹤0.01% | 3318 |
|
|
2025
Q3 | $1.7K | Hold |
571
| – | – | ﹤0.01% | 3435 |
|
|
2025
Q2 | $1.08K | Hold |
571
| – | – | ﹤0.01% | 3373 |
|
|
2025
Q1 | $834 | Hold |
571
| – | – | ﹤0.01% | 3308 |
|
|
2024
Q4 | $1.06K | Hold |
571
| – | – | ﹤0.01% | 3296 |
|
|
2024
Q3 | $1.35K | Hold |
571
| – | – | ﹤0.01% | 3190 |
|
|
2024
Q2 | $1.57K | Hold |
571
| – | – | ﹤0.01% | 3151 |
|
|
2024
Q1 | $2.39K | Hold |
571
| – | – | ﹤0.01% | 3013 |
|
|
2023
Q4 | $1.85K | Hold |
571
| – | – | ﹤0.01% | 3073 |
|
|
2023
Q3 | $1.71K | Hold |
571
| – | – | ﹤0.01% | 2976 |
|
|
2023
Q2 | $651 | Hold |
571
| – | – | ﹤0.01% | 3149 |
|
|
2023
Q1 | $954 | Hold |
571
| – | – | ﹤0.01% | 3034 |
|
|
2022
Q4 | $708 | Hold |
571
| – | – | ﹤0.01% | 3086 |
|
|
2022
Q3 | $2K | Hold |
571
| – | – | ﹤0.01% | 2849 |
|
|
2022
Q2 | $2K | Hold |
571
| – | – | ﹤0.01% | 2889 |
|
|
2022
Q1 | $3K | Hold |
571
| – | – | ﹤0.01% | 2836 |
|
|
2021
Q4 | $3K | Hold |
571
| – | – | ﹤0.01% | 2872 |
|
|
2021
Q3 | $2K | Hold |
571
| – | – | ﹤0.01% | 2821 |
|
|
2021
Q2 | $2K | Hold |
571
| – | – | ﹤0.01% | 2788 |
|
|
2021
Q1 | $3K | Hold |
571
| – | – | ﹤0.01% | 2516 |
|
|
2020
Q4 | $2K | Hold |
571
| – | – | ﹤0.01% | 2505 |
|
|
2020
Q3 | $2K | Hold |
571
| – | – | ﹤0.01% | 2323 |
|
|
2020
Q2 | $2K | Hold |
571
| – | – | ﹤0.01% | 2206 |
|
|
2020
Q1 | $2K | Hold |
571
| – | – | ﹤0.01% | 2226 |
|
|
2019
Q4 | $2K | Hold |
571
| – | – | ﹤0.01% | 2200 |
|
|
2019
Q3 | $2K | Hold |
571
| – | – | ﹤0.01% | 2253 |
|
|
2019
Q2 | $2K | Hold |
571
| – | – | ﹤0.01% | 2292 |
|
|
2019
Q1 | $2K | Hold |
571
| – | – | ﹤0.01% | 2287 |
|
|
2018
Q4 | $2K | Hold |
571
| – | – | ﹤0.01% | 2177 |
|
|
2018
Q3 | $8K | Sell |
571
-25
| -4% | -$365 | ﹤0.01% | 1972 |
|
|
2018
Q2 | $9K | Buy |
596
+25
| +4% | +$407 | ﹤0.01% | 1857 |
|
|
2018
Q1 | $9K | Sell |
571
-286
| -33% | -$5.07K | ﹤0.01% | 1771 |
|
|
2017
Q4 | $12K | Buy |
857
+286
| +50% | +$4.22K | ﹤0.01% | 1668 |
|
|
2017
Q3 | $7K | Buy |
+571
| New | +$7.31K | ﹤0.01% | 1732 |
|
Other funds holding ARMP
MAM
DIG
Northwestern Mutual Wealth Management's ARMP Position: Q2 2026 in Review
Northwestern Mutual Wealth Management held its Armata Pharmaceuticals (ARMP) position steady in Q2 2026 at 571 shares worth $3.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3491.
Northwestern Mutual Wealth Management first reported a position in ARMP in Q3 2017 and has held it in 36 quarters since. The position peaked at $12K in Q4 2017. 53 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.
- Northwestern Mutual Wealth Management held 571 shares of Armata Pharmaceuticals worth $3.7K as of Q2 2026.
- Northwestern Mutual Wealth Management left its Armata Pharmaceuticals share count unchanged in Q2 2026.
- Armata Pharmaceuticals made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #3491 holding.
- Northwestern Mutual Wealth Management first reported a position in Armata Pharmaceuticals in Q3 2017 and has held it in 36 quarters since.
- Northwestern Mutual Wealth Management's Armata Pharmaceuticals position peaked at $12K in Q4 2017.
- 53 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.